Alexander's, Inc. (ALX) Financial Statements
Alexander's, Inc. (ALX) reported trailing twelve-month revenue of $214.8M (down 1.5% year on year) and net income of $169.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $14.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALXAlexander's, Inc.Follow ALX — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- 7.2%
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.23 | 0.23 | 0.20 | 0.21 | 0.21 | 0.22 | 0.23 | 0.21 | 0.21 | |
| Operating income | 0.10 | — | — | — | — | — | — | — | — | |
| Pre-tax income | 0.06 | 0.06 | 0.04 | 0.13 | 0.06 | 0.10 | 0.04 | 0.03 | 0.17 | |
| Income tax | 0.00 | — | — | — | — | — | — | — | — | |
| Net income | 0.03 | 0.06 | 0.04 | 0.13 | 0.06 | 0.10 | 0.04 | 0.03 | 0.17 | |
| Diluted EPS ($) | 6.42 | 11.74 | 8.19 | 25.94 | 11.24 | 19.97 | 8.46 | 5.50 | 33.06 | |
| Diluted shares (bn) | — | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | — |
USD billions · SEC XBRL
Alexander's, Inc. — questions
- What is Alexander's, Inc.'s revenue?
- $214.8M over the twelve months to 2026-06-30, down 1.5% year on year, from its 10-Q and 10-K filings.
- What is Alexander's, Inc.'s net income?
- $169.8M over the twelve months to 2026-06-30.
- What is Alexander's, Inc.'s free cash flow?
- $14.5M over the twelve months to 2026-06-30.
- What are Alexander's, Inc.'s diluted earnings per share?
- $33.06 over the twelve months to 2026-06-30.
Every figure on this page comes from Alexander's, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.